Cardiovascular diseases (CVDs) and neurological diseases are widespread diseases with
substantial rates of morbidity and mortality around the world. For the past few years, the …

In heart failure with reduced ejection fraction and heart failure with preserved ejection
fraction, profound cellular and molecular changes have recently been documented in the …

Cervical cancer, one of the most common malignancies, has a poor survival rate. The
identification of more biomarkers for cervical cancer diagnosis and therapy is urgently …

Direct reprogramming, inducing the conversion of one type of somatic cell into another by
the forced expression of defined transcription factors, is a technology with anticipated …

The activation of phospholipase C (PLC) is thought to have a key role in the cardiomyocyte
response to several different hypertrophic agents such as norepinephrine, angiotensin II and …

Familial hypertrophic cardiomyopathy (HCM) is a significant precursor of heart failure and
sudden cardiac death, primarily caused by mutations in sarcomeric and structural proteins …

Abstract Background Cardiac Myxoma is a primary tumor of heart. Its origins, rarity of the
occurrence of primary cardiac tumors and how it may be related to limited cardiac …

Vincristine (VCR), a vinca alkaloid with anti-tumor and anti-oxidant properties, is acclaimed
to possess cardioprotective action. However, the molecular mechanism underlying this …

Adverse cardiac remodeling after acute myocardial infarction is the most important
pathological mechanism of heart failure and remains a major problem in clinical practice …

Background: Breast cancer remains a pervasive global health concern among women, with
conventional therapies such as chemotherapeutic agents, radiography, and surgery lacking …